Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twelve research firms that are presently covering the company, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $87.82.
A number of equities research analysts recently weighed in on the company. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and boosted their price objective for the stock from $66.00 to $88.00 in a research report on Monday. Jefferies Financial Group initiated coverage on GE HealthCare Technologies in a research report on Thursday, November 30th. They set a “hold” rating and a $80.00 price objective on the stock. Mizuho upped their price target on GE HealthCare Technologies from $94.00 to $96.00 and gave the company a “buy” rating in a research report on Wednesday, February 7th. Finally, Morgan Stanley upped their price target on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research report on Monday.
GE HealthCare Technologies Price Performance
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. The business had revenue of $5.20 billion for the quarter, compared to analyst estimates of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. GE HealthCare Technologies’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.31 EPS. On average, sell-side analysts expect that GE HealthCare Technologies will post 4.3 earnings per share for the current fiscal year.
GE HealthCare Technologies Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Tuesday, January 16th will be given a dividend of $0.03 per share. The ex-dividend date of this dividend is Friday, January 12th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s payout ratio is 3.97%.
Institutional Investors Weigh In On GE HealthCare Technologies
Several institutional investors and hedge funds have recently made changes to their positions in GEHC. Fiduciary Trust Co raised its stake in GE HealthCare Technologies by 1.8% during the 4th quarter. Fiduciary Trust Co now owns 7,696 shares of the company’s stock worth $595,000 after buying an additional 133 shares during the period. Janney Capital Management LLC raised its stake in GE HealthCare Technologies by 4.7% during the 4th quarter. Janney Capital Management LLC now owns 3,289 shares of the company’s stock worth $254,000 after buying an additional 149 shares during the period. American National Bank raised its stake in shares of GE HealthCare Technologies by 25.2% in the fourth quarter. American National Bank now owns 750 shares of the company’s stock worth $58,000 after purchasing an additional 151 shares during the last quarter. Armstrong Henry H Associates Inc. raised its stake in shares of GE HealthCare Technologies by 3.9% in the third quarter. Armstrong Henry H Associates Inc. now owns 4,105 shares of the company’s stock worth $279,000 after purchasing an additional 153 shares during the last quarter. Finally, Chicago Capital LLC raised its stake in shares of GE HealthCare Technologies by 2.8% in the third quarter. Chicago Capital LLC now owns 6,081 shares of the company’s stock worth $414,000 after purchasing an additional 163 shares during the last quarter. Institutional investors own 79.18% of the company’s stock.
About GE HealthCare Technologies
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally.
- Five stocks we like better than GE HealthCare Technologies
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 attractive stocks that insiders are buying
- Pros And Cons Of Monthly Dividend Stocks
- Alpha and Omega Semiconductor ready to bounce, DOJ cloud lifts
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Wendy’s vs Shake Shack: Out with the new, in with the old?
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.